Can anyone help me understand the continued #radiopharmaceuticals work with girentuximab given that a phase 2 published in 2016 was underwhelming?
I’m surely missing something.
#oncology #nucmed #radonc
https://www.sciencedirect.com/science/article/pii/S030228381501204X
Mastodon is the best way to keep up with what's happening.
Follow anyone across the fediverse and see it all in chronological order. No algorithms, ads, or clickbait in sight.